435 related articles for article (PubMed ID: 28934744)
1. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
2. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.
Dieter BP; McPherson SM; Afkarian M; de Boer IH; Mehrotra R; Short R; Barbosa-Leiker C; Alicic RZ; Meek RL; Tuttle KR
J Diabetes Complications; 2016; 30(8):1467-1472. PubMed ID: 27522272
[TBL] [Abstract][Full Text] [Related]
4. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
[TBL] [Abstract][Full Text] [Related]
5. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
[TBL] [Abstract][Full Text] [Related]
6. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.
Pavkov ME; Knowler WC; Hanson RL; Williams DE; Lemley KV; Myers BD; Nelson RG
Am J Kidney Dis; 2013 Jul; 62(1):33-41. PubMed ID: 23347458
[TBL] [Abstract][Full Text] [Related]
8. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
[TBL] [Abstract][Full Text] [Related]
9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
10. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
[TBL] [Abstract][Full Text] [Related]
11. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.
Vaisar T; Durbin-Johnson B; Whitlock K; Babenko I; Mehrotra R; Rocke DM; Afkarian M
Diabetes Care; 2018 Nov; 41(11):2361-2369. PubMed ID: 30150236
[TBL] [Abstract][Full Text] [Related]
12. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
[TBL] [Abstract][Full Text] [Related]
13. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
14. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
Tofik R; Torffvit O; Rippe B; Bakoush O
Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
[TBL] [Abstract][Full Text] [Related]
15. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
[TBL] [Abstract][Full Text] [Related]
16. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.
Pavkov ME; Knowler WC; Hanson RL; Bennett PH; Nelson RG
Am J Kidney Dis; 2008 May; 51(5):759-66. PubMed ID: 18436086
[TBL] [Abstract][Full Text] [Related]
17. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
18. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
19. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
[TBL] [Abstract][Full Text] [Related]
20. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).
Amin AP; Whaley-Connell AT; Li S; Chen SC; McCullough PA; Kosiborod MN;
Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S12-23. PubMed ID: 23507266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
